Skip to content
10-Q

Quarterly Report

REGENERX BIOPHARMACEUTICALS, INC.

0001410578-22-002406

← back to feed
Filed
Aug 12, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · Aug 8, 2022 143.55M sh
Shares Diluted Q2 2022 · Jun 30, 2022 143.55M sh
Shares Diluted Q2 2022 · Jun 30, 2022 143.55M sh
Shares Diluted Q2 2022 · Jun 30, 2021 133.66M sh
Shares Diluted Q2 2022 · Jun 30, 2021 134.33M sh
Operating Cash Flow Q2 2022 · Jun 30, 2022 −$524.96K
Operating Cash Flow Q2 2022 · Jun 30, 2021 −$267.87K
Cash And Equivalents Q2 2022 · Jun 30, 2022 $706.65K
Cash And Equivalents Q2 2022 · Dec 31, 2021 $1.23M
Stockholders Equity Q2 2022 · Jun 30, 2022 −$2.86M
Stockholders Equity Q2 2022 · Mar 31, 2022 −$2.57M
Stockholders Equity Q2 2022 · Dec 31, 2021 −$2.23M
Stockholders Equity Q2 2022 · Jun 30, 2021 −$1.55M
Stockholders Equity Q2 2022 · Mar 31, 2021 −$3.12M
Stockholders Equity Q2 2022 · Dec 31, 2020 −$2.82M
Current Liabilities Q2 2022 · Jun 30, 2022 $432.85K
Current Liabilities Q2 2022 · Dec 31, 2021 $429.93K
Total Liabilities Q2 2022 · Jun 30, 2022 $3.6M
Total Liabilities Q2 2022 · Dec 31, 2021 $3.51M
Current Assets Q2 2022 · Jun 30, 2022 $725.6K
Current Assets Q2 2022 · Dec 31, 2021 $1.25M
Total Assets Q2 2022 · Jun 30, 2022 $735.5K
Total Assets Q2 2022 · Dec 31, 2021 $1.28M
Eps Diluted Q2 2022 · Jun 30, 2022 $0.00
Eps Diluted Q2 2022 · Jun 30, 2022 −$0.01
Eps Diluted Q2 2022 · Jun 30, 2021 $0.00
Eps Diluted Q2 2022 · Jun 30, 2021 −$0.01
Eps Basic Q2 2022 · Jun 30, 2022 $0.00
Eps Basic Q2 2022 · Jun 30, 2022 −$0.01
Eps Basic Q2 2022 · Jun 30, 2021 $0.00
Eps Basic Q2 2022 · Jun 30, 2021 −$0.01
Sga Expense Q2 2022 · Jun 30, 2022 $484.03K
Sga Expense Q2 2022 · Jun 30, 2022 $847.06K
Sga Expense Q2 2022 · Jun 30, 2021 $276.15K
Sga Expense Q2 2022 · Jun 30, 2021 $594.27K
Rd Expense Q2 2022 · Jun 30, 2022 $0
Rd Expense Q2 2022 · Jun 30, 2022 $0
Rd Expense Q2 2022 · Jun 30, 2021 $487
Rd Expense Q2 2022 · Jun 30, 2021 $975
Net Income Q2 2022 · Jun 30, 2022 −$545.98K
Net Income Q2 2022 · Jun 30, 2022 −$970.04K
Net Income Q2 2022 · Mar 31, 2022 −$424.07K
Net Income Q2 2022 · Jun 30, 2021 −$338.63K
Net Income Q2 2022 · Jun 30, 2021 −$718.33K
Net Income Q2 2022 · Mar 31, 2021 −$379.69K
Operating Income Q2 2022 · Jun 30, 2022 −$464.84K
Operating Income Q2 2022 · Jun 30, 2022 −$808.68K
Operating Income Q2 2022 · Jun 30, 2021 −$257.45K
Operating Income Q2 2022 · Jun 30, 2021 −$556.86K
Revenue Q2 2022 · Jun 30, 2022 $19.19K
Revenue Q2 2022 · Jun 30, 2022 $38.38K
Revenue Q2 2022 · Jun 30, 2021 $19.19K
Revenue Q2 2022 · Jun 30, 2021 $38.38K